<DOC>
	<DOCNO>NCT01429389</DOCNO>
	<brief_summary>The specimen collection design purpose development noninvasive prenatal test T21 .</brief_summary>
	<brief_title>Specimen Collection From Pregnant Women Increased Risk Fetal Aneuploidy</brief_title>
	<detailed_description>To collect specimen purpose develop prenatal aneuploidy test . The test analyze circulate cell free fetal ( ccff ) nucleic acid blood sample pregnant woman increase risk indicator/s fetal chromosomal aneuploidy undergo invasive prenatal diagnosis chorionic villus sampling ( CVS ) and/or genetic amniocentesis . The result ccff aneuploidy test compare chromosomal analysis obtain via CVS genetic amniocentesis .</detailed_description>
	<mesh_term>Down Syndrome</mesh_term>
	<mesh_term>Aneuploidy</mesh_term>
	<criteria>pregnant 10 22 week gestation 18 year age old provide sign date informed consent subject increase risk fetal aneuploidy subject willing undergo CVS and/or amniocentesis procedure purpose genetic analysis subject agree provide genetic result invasive procedure Fetal demise time specimen sample Previous sample donation protocol</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Down syndrome</keyword>
	<keyword>fetal aneuploidy</keyword>
	<keyword>trisomy</keyword>
	<keyword>noninvasive screening test</keyword>
</DOC>